| Armodafinil | Post-Market | Excessive Sleepiness |
| Fremanezumab | Post-Market | Migraine |
| AGEE cream | Post-Market | Multiple Sclerosis |
| HYDROCORTISONE | Approved | |
| STATOBEX | Approved | |
| LEUCOVORIN CALCIUM | Approved | |
| DIMENHYDRINATE | Approved | |
| LOXITANE C | Approved | |
| MEPROBAMATE | Approved | |
| HYDROCHLOROTHIAZIDE W/ RESERPINE | Approved | |
| CLOTRIMAZOLE | Approved | |
| DIAMOX | Approved | |
| PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE | Approved | |
| NALTREXONE | Approved | |
| QUINIDINE SULFATE | Approved | |
| DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | Approved | |
| ADENOSINE | Approved | |
| CORTISONE ACETATE | Approved | |
| ETHOSUXIMIDE | Approved | |
| CARBOPLATIN | Approved | |
| IRINOTECAN HYDROCHLORIDE | Approved | |
| FLUCONAZOLE | Approved | |
| LEVALBUTEROL HYDROCHLORIDE | Approved | |
| BUPRENORPHINE | Approved | |
| DULOXETINE HYDROCHLORIDE | Approved | |
| PREDNISOLONE | Approved | |
| ESTRADIOL | Approved | |
| FLUTICASONE PROPIONATE AND SALMETEROL | Approved | |
| CEFACLOR | Approved | |
| DALBAVANCIN | Approved | |
| ASPIRIN; OMEPRAZOLE | Approved | |
| DEXMEDETOMIDINE HYDROCHLORIDE | Approved | |
| ROCURONIUM BROMIDE | Approved | |
| FERRIC CITRATE | Approved | |
| MONTELUKAST SODIUM | Approved | |
| POMALIDOMIDE | Approved | |
| MEXILETINE HYDROCHLORIDE | Approved | |
| SILDENAFIL | Approved | |
| ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE | Approved | |
| ENTECAVIR | Approved | |
| WELTRUZA | Approved | |
| Bendamustine HCl | Phase 3 | Non-Hodgkin's Lymphoma |
| rasagiline mesylate | Phase 3 | Parkinson's Disease |
| Fp MDPI | Phase 3 | Persistent Asthma |
| TVB-009 | Phase 3 | Osteoporosis, Postmenopausal |
| Albuterol Sulfate | Phase 3 | Asthma |
| CEP-10953 (Armodafinil) | Phase 3 | Narcolepsy |
| Gabitril | Phase 3 | Generalized Anxiety Disorder |
| TV-1106 | Phase 3 | Growth Hormone Deficiency |
| Tapinarof Cream 1% | Phase 3 | Plaque Type Psorisis |
| custirsen sodium | Phase 3 | Castrate-Resistant Prostate Cancer |
| Imiquimod Cream, 3.75% | Phase 3 | Actinic Keratosis |
| Modafinil | Phase 3 | Sleep Apnea, Obstructive |
| OraVescent Fentanyl | Phase 3 | Low Back Pain |
| Fluticasone Propionate and Salmeterol Inhalation Powder | Phase 3 | Asthma |
| Balugrastim | Phase 2/3 | Chemotherapy-induced Neutropenia |
| inhaled delta-8-THC 300mcg or 600mcg per dose | Phase 2 | Cancer |
| CEP-701 60mg | Phase 2 | Leukemia, Myeloid |
| TEV-53275 Dose A | Phase 2 | Asthma |
| Larazotide Acetate | Phase 2 | Celiac Disease |
| Talampanel | Phase 2 | Epilepsy |
| Fentanyl | Phase 2 | Cancer |
| Omacetaxine mepesuccinate | Phase 1/2 | Chronic Myeloid Leukemia |
| CEP-37247 | Phase 1/2 | Sciatica |
| Modakafusp Alfa | Phase 1/2 | Multiple Myeloma |
| Obatoclax mesylate (GX15-070MS) | Phase 1 | Hematological Malignancies |
| CEP-26401 | Phase 1 | Cognitive Impairment |
| Venlafaxine 25 mg Tablets | Phase 1 | Healthy |
| Cilostazol 50 mg Tablets | Phase 1 | Healthy |
| TV-46046 | Phase 1 | Contraception |
| amoxicillin-clavulanic acid | Phase 1 | Healthy |
| Ropinirole HCl 0.25 mg Tablets | Phase 1 | Healthy |
| Fluoxetine Hydrochloride | Phase 1 | Healthy |
| TL011 | Phase 1 | DLBCL |
| hGH-ViaDerm™ System (hGH or somatropin) | Phase 1 | Growth Hormone Deficiency |
| Trandolapril 4 mg Tablets | Phase 1 | Healthy |
| 600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL | Phase 1 | Healthy |
| Terbinafine HCl 250mg tablets | Phase 1 | Healthy |
| Lansoprazole | Phase 1 | Healthy |
| Doxycycline Monohydrate | Phase 1 | Healthy |
| Topiramate 25 mg Capsules | Phase 1 | Healthy |
| Cefprozil for oral suspension 250 mg/5 mL | Phase 1 | Healthy |
| 45-mg hydrocodone bitartrate extended-release tablet (crushed or intact) | Phase 1 | Drug Abuse |
| Copaxone | Not Applicable | Multiple Sclerosis |